Patent · US Active

β-lactamase inhibitors

US10738051B2 · kind B2 · utility

0Cited by

0References

7Claims

0Family size

Assignee

QILU PHARMACEUTICAL CO., LTD. · CN

Inventors

Boyu HU · Lianyungang, CN
Charles Z. Ding · San Mateo, US
Zhigang Huang · Longbeilingcun, CN
Ruibin Lin · Shanghai, CN
Minliang Xiao · Shanghai, CN
Jinsheng Xie · Zhejiang, CN
Shuhui CHEN · Shanghai, CN
Cheng LI · Shanghai, CN

Key dates

Filing date	Jun 2, 2017
Grant date	Aug 11, 2020
Priority date	—
Expiry date	Jun 13, 2037

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Disclosed in the present invention is a type of novel β-lactamase inhibitors, and specifically disclosed are a compound represented by formula (I) or a pharmaceutically acceptable salt thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.